This article was originally published in The Gray Sheet
Executive SummarySecond $5 mil. installment of total $10 mil. Series A financing from Credit Suisse First Boston, Cyberfund and Hammer Capital is triggered by initial scale-up of the LifeShirt ambulatory monitoring system. The device, which continuously collects respiratory and heart rate data, blood-oxygen saturation levels, ECG waveform and systolic and diastolic heart function measures, will now be clinically evaluated in preparation for a 510(k) submission, Ventura, California-based VivoMetrics reports
You may also be interested in...
The North American trade organization’s new website offers consumers a gateway into the world of fragrance. Providing a “deep dive” into 50 fragrance ingredients, as well as overviews of perfumery, key regulations, and industry safety practices and sustainability efforts, the site extends FCA’s work to engage and inform consumers at a time of growing interest in manufactured scents.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.